drugmakers

مستقر11 خبر4 مصادرآخر تحديث: 6 g önce

أحدث الأخبار

Drugmakers Envision Future of Obesity Treatments Beyond GLP-1s

Drugmakers are exploring new obesity treatments beyond GLP-1s, including less frequent shots and pills with fewer side effects. Eli Lilly's experimental drug retatrutide showed significant weight loss, while competitors like Novo Nordisk, Structure Therapeutics, AstraZeneca, Pfizer, and Amgen are developing new oral and injectable options. The market is expected to grow significantly, with pricing and insurance coverage being key factors.

CNBC US Markets

GSK to Acquire Nuvalent for $10.6 Billion to Boost Oncology Pipeline

خبر

10.06.2026ملخص الذكاء الاصطناعي

GSK to Acquire Nuvalent for $10.6 Billion to Boost Oncology Pipeline

GSK acquires Nuvalent for $10.6B to bolster oncology pipeline with late-stage lung cancer treatments, aiming to offset future revenue drop from losing HIV medicine exclusivity.

CNBC

Supreme Court Allows Mail Orders of Abortion Drug Mifepristone Pending Appeal

يتطور

Law·14.05.2026ملخص الذكاء الاصطناعي

Supreme Court Allows Mail Orders of Abortion Drug Mifepristone Pending Appeal

The Supreme Court has temporarily allowed mail orders of the abortion drug mifepristone while an appeal by Louisiana against the FDA's distribution rules is pending, with Justices Thomas and Alito dissenting.

CNBC

FDA Commissioner Dr. Marty Makary Resigns Amid Controversy

سياسة

12.05.2026ملخص الذكاء الاصطناعي

FDA Commissioner Dr. Marty Makary Resigns Amid Controversy

Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner

CNBC US Markets

Trump says Makary is out as FDA commissioner, following industry and White House backlash

خبر

12.05.2026

Trump says Makary is out as FDA commissioner, following industry and White House backlash

Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

CNBC US Markets

خبر

12.05.2026

New EU medicines law aims to bypass India, China on key drugs

The EU wants to incentivise drugmakers to manufacture more medicines in Europe through state aid and procurement perks.

Politico EU

خبر

04.05.2026

Supreme Court temporarily lifts mail ban on abortion pill mifepristone

Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to restore the ability to order Mifepristone through the mail.

CNBC

خبر

04.05.2026

Supreme Court temporarily blocks mail ban on abortion pill mifepristone

Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to restore the ability to order Mifepristone through the mail.

CNBC

خبر

04.05.2026

Supreme Court temporarily blocks mail ban on abortion pill Mifepristone

Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to restore the ability to order Mifepristone through the mail.

CNBC

Regeneron Cuts Drug Prices for Some Americans in Trump Deal, Offers Free Gene Therapy

يتطور

صحة·23.04.2026ملخص الذكاء الاصطناعي

Regeneron Cuts Drug Prices for Some Americans in Trump Deal, Offers Free Gene Therapy

Regeneron agreed to lower U.S. drug prices for some Americans under a deal with President Trump, part of his 'most favored nation' effort to align U.S. prices with lower international rates. The biotech company will also offer its newly FDA-approved hearing-loss gene therapy Otarmeni for free to eligible patients. The agreements exempt companies from tariffs for three years, including planned up to 100% levies on pharmaceuticals. The FDA approved Otarmeni under its National Priority Voucher program for an ultra-rare genetic condition causing deafness.

CNBC

Bayer Warns of Higher Drug Prices in Europe Amid US Pricing Pressure

يتطور

Business·13.04.2026ملخص الذكاء الاصطناعي

Bayer Warns of Higher Drug Prices in Europe Amid US Pricing Pressure

Bayer's pharmaceutical head Stefan Oelrich warns that European drug prices must rise to maintain profitability as US policies force companies to lower costs for American consumers, leading to a decline in new drug launches across Europe.

RT Business